Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Recruiting 4Active not recruiting 2

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 4

Conditions

Breast Neoplasms 1217Neoplasms 1027Carcinoma, Non-Small-Cell Lung 749Prostatic Neoplasms 688Colorectal Neoplasms 593Lung Neoplasms 573Pancreatic Neoplasms 394Leukemia, Myeloid, Acute 394Neoplasm Metastasis 388Ovarian Neoplasms 370Multiple Myeloma 369Stomach Neoplasms 316Carcinoma, Hepatocellular 301Melanoma 281Brain Neoplasms 277Recurrence 273Squamous Cell Carcinoma of Head and Neck 269Head and Neck Neoplasms 237Endometrial Neoplasms 234Glioblastoma 233Triple Negative Breast Neoplasms 228Uterine Cervical Neoplasms 221Precursor Cell Lymphoblastic Leukemia-Lymphoma 221Lymphoma 221Sarcoma 201Hematologic Neoplasms 199Urinary Bladder Neoplasms 196Esophageal Neoplasms 190Carcinoma, Renal Cell 188Lymphoma, Non-Hodgkin 176

Interventions

atezolizumab 1Immune Checkpoint Inhibitors 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × SCLC × 1 year × Clear all
NCT07416695 2026-04-29

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC

Shanghai Henlius Biotech

Phase 1 Recruiting
138 enrolled
Thoracic

SCLC

NCT06179069 2026-04-03

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Zai Lab (Hong Kong), Ltd.

Phase 1 Recruiting
339 enrolled
Thoracic

SCLC

NCT07110103 2026-02-27

JACKPOT38

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting
20 enrolled
Thoracic

SCLC

NCT06021483 2025-09-16

Observational Study to Evaluate the Safety and Efficacy of Zepzelcaâ„¢ Injection

Boryung Pharmaceutical Co., Ltd

Recruiting
300 enrolled
Thoracic

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡